Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus.
Animals
Antigens, Viral
/ genetics
CD8-Positive T-Lymphocytes
/ immunology
Cells, Cultured
Disease Models, Animal
Glycoproteins
/ genetics
Immune Evasion
Immunodominant Epitopes
/ genetics
Lymphocytic Choriomeningitis
/ immunology
Lymphocytic choriomeningitis virus
/ physiology
Mice
Mice, Inbred C57BL
Mice, Knockout
Peptide Fragments
/ genetics
Viral Proteins
/ genetics
CD8 T cell
CTL escape mutation
immune evasion
lymphocytic choriomeningitis (LCMV)
mouse model
viral infection
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
12
2020
accepted:
25
05
2021
entrez:
1
7
2021
pubmed:
2
7
2021
medline:
29
10
2021
Statut:
epublish
Résumé
Cytotoxic T lymphocytes (CTLs) represent key immune effectors of the host response against chronic viruses, due to their cytotoxic response to virus-infected cells. In response to this selection pressure, viruses may accumulate escape mutations that evade CTL-mediated control. To study the emergence of CTL escape mutations, we employed the murine chronic infection model of lymphocytic choriomeningitis virus (LCMV). We developed an amplicon-based next-generation sequencing pipeline to detect low frequency mutations in the viral genome and identified non-synonymous mutations in the immunodominant LCMV CTL epitope, GP33-41, in infected wildtype mice. Infected Rag2-deficient mice lacking CTLs did not contain such viral mutations. By using transgenic mice with T cell receptors specific to GP33-41, we characterized the emergence of viral mutations in this epitope under varying selection pressure. We investigated the two most abundant viral mutations by employing reverse genetically engineered viral mutants encoding the respective mutations. These experiments provided evidence that these mutations prevent activation and expansion of epitope-specific CD8 T cells. Our findings on the mutational dynamics of CTL escape mutations in a widely-studied viral infection model contributes to our understanding of how chronic viruses interact with their host and evade the immune response. This may guide the development of future treatments and vaccines against chronic infections.
Identifiants
pubmed: 34194424
doi: 10.3389/fimmu.2021.638485
pmc: PMC8236698
doi:
Substances chimiques
Antigens, Viral
0
Glycoproteins
0
Immunodominant Epitopes
0
Peptide Fragments
0
Viral Proteins
0
glycoprotein peptide 33-41, Lymphocytic choriomeningitis virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
638485Informations de copyright
Copyright © 2021 Smyth, Khamina, Popa, Gudipati, Agerer, Lercher, Kosack, Endler, Baazim, Viczenczova, Huppa and Bergthaler.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Immunol Rev. 2003 Jun;193:31-8
pubmed: 12752668
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4663-8
pubmed: 16537369
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Adv Exp Med Biol. 2015;850:137-52
pubmed: 26324351
Nat Rev Immunol. 2016 Jul;16(7):421-32
pubmed: 27265595
J Virol. 1995 Nov;69(11):7147-51
pubmed: 7474135
Med Microbiol Immunol. 2015 Feb;204(1):29-38
pubmed: 25537849
Virology. 1997 Jul 21;234(1):62-73
pubmed: 9234947
Nat Med. 2018 Jan 9;24(1):2-5
pubmed: 29315300
J Exp Med. 2005 Jun 6;201(11):1709-14
pubmed: 15939787
Immunity. 2011 Aug 26;35(2):161-8
pubmed: 21867926
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Clin Exp Immunol. 2010 Mar;159(3):245-55
pubmed: 19968665
J Immunol. 2009 Feb 15;182(4):1829-35
pubmed: 19201834
Sci Immunol. 2021 Mar 4;6(57):
pubmed: 33664060
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5
pubmed: 9050875
Immunity. 2001 Dec;15(6):867-70
pubmed: 11754809
Bioinformatics. 2009 Dec 15;25(24):3244-50
pubmed: 19819885
Cancer Immunol Res. 2019 Jan;7(1):50-61
pubmed: 30425106
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3831-6
pubmed: 18245382
Nature. 1990 Aug 16;346(6285):629-33
pubmed: 1696684
J Hepatol. 2021 Jan;74(1):220-229
pubmed: 33002569
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3429-33
pubmed: 1565634
Immunity. 2019 Dec 17;51(6):1074-1087.e9
pubmed: 31784108
Eur J Immunol. 1987 Dec;17(12):1843-6
pubmed: 2961577
J Immunol. 2015 Feb 15;194(4):1755-62
pubmed: 25567678
Nat Med. 2006 Feb;12(2):246-51
pubmed: 16462803
J Virol. 2009 May;83(9):4386-94
pubmed: 19211743
Nat Med. 2004 Mar;10(3):282-9
pubmed: 14770175
J Virol. 2007 Apr;81(8):4137-44
pubmed: 17251297
J Virol. 2001 Jun;75(11):5099-107
pubmed: 11333891
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Nature. 1974 Apr 19;248(5450):701-2
pubmed: 4133807
Virology. 2003 Oct 10;315(1):93-102
pubmed: 14592762
Front Genet. 2012 Mar 15;3:35
pubmed: 22435069
Nature. 2002 Jan 17;415(6869):335-9
pubmed: 11797012
Immunity. 2015 Nov 17;43(5):974-86
pubmed: 26588782
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Immunity. 2001 Dec;15(6):883-95
pubmed: 11754811
Annu Rev Immunol. 2013;31:443-73
pubmed: 23298205
J Virol. 2003 Apr;77(8):4911-27
pubmed: 12663797
J Virol. 2011 Oct;85(20):10518-28
pubmed: 21835793
Curr Top Microbiol Immunol. 2002;263:1-5
pubmed: 11987811
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Int J Exp Pathol. 2001 Oct;82(5):269-86
pubmed: 11703537
J Virol. 2015 Nov;89(21):10802-20
pubmed: 26292326
Nature. 2015 Jan 15;517(7534):381-5
pubmed: 25561180
PLoS One. 2016 Feb 25;11(2):e0149582
pubmed: 26915099
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Nat Med. 1997 Feb;3(2):212-7
pubmed: 9018241
Cell Host Microbe. 2016 Mar 9;19(3):292-303
pubmed: 26922989
Nat Rev Immunol. 2004 Aug;4(8):630-40
pubmed: 15286729
J Virol. 2007 May;81(10):4928-40
pubmed: 17329346
Nat Rev Immunol. 2008 Aug;8(8):619-30
pubmed: 18617886
Nature. 1994 May 5;369(6475):31-7
pubmed: 8164737